Literature DB >> 17867256

Poor glycaemic control is the major factor associated with increased frequency of gastrointestinal symptoms in patients with diabetes mellitus.

Shahab Abid1, Amir Rizvi, Firdous Jahan, Fauziah Rabbani, Najmul Islam, Masood H Khan, Rana Masood, Wasim Jafri.   

Abstract

OBJECTIVE: To compare the GI symptoms in diabetic patients with controls and its relationship with the complications, duration of diabetes and glycaemic control.
METHODS: Consecutive patients were prospectively enrolled in to two groups. Group I (diabetic patients) and Group II (non-diabetic, Controls). Patient's characteristics, demographic profiles and GI symptoms were evaluated on a questionnaire. Groups were compared for differences in various GI symptoms. Group I was further analyzed for the relationship between GI symptoms with complications, duration of diabetes and glycaemic control.
RESULTS: A total of 514 patients were enrolled 250 were diabetics (group I) and 264 were non-diabetics (group II). Mean age was 51.8 +/- 10.6 years and 50.2 +/- 9.2 years in groups i and ii respectively. All GI symptoms; heartburn, dyspepsia, bowel related abdominal pain, diarrhea, constipation, and faecal incontinence were significantly more in diabetics than controls (P < .5). The presence of diabetic neuropathy, retinopathy and HbAlc of > 7 were significantly (P < .5) related to GI symptoms. Duration of diabetes (>10 years) was not found significantly linked to GI symptoms.
CONCLUSIONS: GI symptoms in diabetics were more frequent then control subjects and were significantly associated with poor glycaemic control, neuropathy and retinopathy but not with duration of diabetes. Number of GI symptoms increases with the severity of poor glycaemic control in diabetic patients

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17867256

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  5 in total

1.  ER stress and ER stress-induced apoptosis are activated in gastric SMCs in diabetic rats.

Authors:  Xia Chen; Xiang-Sheng Fu; Chang-Ping Li; Hong-Xian Zhao
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

2.  Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences.

Authors:  Michael Horowitz; Vanita R Aroda; Jenny Han; Elise Hardy; Chris K Rayner
Journal:  Diabetes Obes Metab       Date:  2017-02-17       Impact factor: 6.577

3.  The Prevalence of Enteropathy Symptoms from the Lower Gastrointestinal Tract and the Evaluation of Anorectal Function in Diabetes Mellitus Patients.

Authors:  Małgorzata Reszczyńska; Radosław Kempiński
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

Review 4.  Stem Cell Research Tools in Human Metabolic Disorders: An Overview.

Authors:  Serena Ricci; Pietro Cacialli
Journal:  Cells       Date:  2021-10-07       Impact factor: 6.600

5.  Prevalence of Gastrointestinal Symptoms in Chinese Community-Dwelling Adults with and without Diabetes.

Authors:  Miaomiao Sang; Tongzhi Wu; Xiaoying Zhou; Michael Horowitz; Karen L Jones; Shanhu Qiu; Haijian Guo; Bei Wang; Donglei Wang; Christopher K Rayner; Zilin Sun
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.